# Extracellular matrix mediates circulating tumor cell clustering in triple-negative breast cancer metastasis

**Authors:** Georg OM Bobkov, Khushali J. Patel, Bree M. Lege, Rong Zheng, Gad Shaulsky, Matthew J. Ellis, Chonghui Cheng

PMC · DOI: 10.1038/s41467-026-69007-w · Nature Communications · 2026-02-06

## TL;DR

This paper shows how tumor cells in aggressive breast cancer form clusters using hyaluronan, which helps them spread more effectively.

## Contribution

The study reveals a novel ECM-mediated mechanism for CTC clustering in TNBCs lacking epithelial adhesion proteins.

## Key findings

- Hyaluronan (HA) mediates CTC clustering independently of epithelial adherens junction proteins.
- HA initiates cell-cell contact via actin-based protrusions and stabilizes interactions through desmosomes.
- HA also promotes heterotypic clusters by recruiting non-CTC cells like immune cells.

## Abstract

Metastatic tumor cell dissemination is the leading cause of cancer-related deaths. Clustered circulating tumor cells (CTCs) possess higher metastatic potential than single CTCs. Epithelial adherens junction (AJ) proteins typically mediate stable cell-cell interactions; however, these proteins are frequently lost in highly aggressive triple-negative breast cancers (TNBCs), raising the question of how CTCs from such tumors cluster. Here we show that the extracellular matrix (ECM) component hyaluronan (HA) mediates AJ-independent CTC clustering in TNBCs. HA is necessary and sufficient to drive clustering of tumor cells expressing its receptor CD44. Mechanistically, HA initiates contact between neighboring cells through actin-based membrane protrusions. As cells are pulled closer, these initial interactions expand to membrane-membrane contact and are subsequently stabilized by desmosomes. CTC-derived HA also acts as a docking platform to promote heterotypic cluster formation by recruiting non-CTCs, including immune cells. Thus, this ECM–receptor interaction enables CTC clustering and survival under shear stress, enhancing TNBC metastasis.

Circulating tumor cell (CTC) clusters are key drivers of metastasis, yet their formation in tumors lacking classical adhesion molecules is unclear. Here, the authors discover that hyaluronic acid promotes homotypic and heterotypic CTC clustering by initiating early cell contacts and stabilizing mature interactions.

## Linked entities

- **Proteins:** CD44 (CD44 molecule (IN blood group))
- **Diseases:** triple-negative breast cancer (MONDO:0005494), breast cancer (MONDO:0004989)

## Full-text entities

- **Genes:** KRT19 (keratin 19) [NCBI Gene 3880] {aka CK19, K19, K1CS}, Ctrl (chymotrypsin-like) [NCBI Gene 109660] {aka 0910001G08Rik, 1810004D15Rik, Ctra-1, Ctra1, chymopasin, mFLJ00366}, Dsg2 (desmoglein 2) [NCBI Gene 13511] {aka D18Ertd293e}, HAS2 (hyaluronan synthase 2) [NCBI Gene 3037], EPCAM (epithelial cell adhesion molecule) [NCBI Gene 4072] {aka Ber-Ep4, BerEp4, DIAR5, EGP-2, EGP314, EGP40}, BRCA1 (BRCA1 DNA repair associated) [NCBI Gene 672] {aka BRCAI, BRCC1, BROVCA1, FANCS, IRIS, PNCA4}, Mki67 (antigen identified by monoclonal antibody Ki 67) [NCBI Gene 17345] {aka D630048A14Rik, Ki-67, Ki67}, Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 14433] {aka Gapd}, Cd44 (CD44 antigen) [NCBI Gene 12505] {aka HERMES, Ly-24, Pgp-1}, Has2 (hyaluronan synthase 2) [NCBI Gene 15117], Dsp (desmoplakin) [NCBI Gene 109620] {aka 2300002E22Rik, 5730453H04Rik, DP, rul}, Erbb2 (erb-b2 receptor tyrosine kinase 2) [NCBI Gene 13866] {aka Erbb-2, HER-2, HER2, Neu, c-erbB2, c-neu}, CD44 (CD44 molecule (IN blood group)) [NCBI Gene 960] {aka CDW44, CSPG8, ECM-III, ECMR-III, H-CAM, HCELL}, Trim27 (tripartite motif-containing 27) [NCBI Gene 19720] {aka Gm19403, Rfp}, Ly6g (lymphocyte antigen 6 family member G) [NCBI Gene 546644] {aka Gr-1, Gr1, Ly-6G}, Egf (epidermal growth factor) [NCBI Gene 13645], Tbp (TATA box binding protein) [NCBI Gene 21374] {aka GTF2D1, Gtf2d, SCA17, TFIID}, HAS1 (hyaluronan synthase 1) [NCBI Gene 3036] {aka HAS}, Actb (actin, beta) [NCBI Gene 11461] {aka Actx, E430023M04Rik, beta-actin}, Akt1 (Akt serine/threonine kinase 1) [NCBI Gene 11651] {aka Akt, LTR-akt, PKB, PKB/Akt, PKBalpha, Rac}, Dsc2 (desmocollin 2) [NCBI Gene 13506], HAS3 (hyaluronan synthase 3) [NCBI Gene 3038], Cdh1 (cadherin 1) [NCBI Gene 12550] {aka ARC-1, E-cad, Ecad, L-CAM, UVO, Um}, ADA2 (adenosine deaminase 2) [NCBI Gene 51816] {aka ADGF, CECR1, IDGFL, PAN, SNEDS, VAIHS}, Efs (embryonal Fyn-associated substrate) [NCBI Gene 13644], EGFR (epidermal growth factor receptor) [NCBI Gene 1956] {aka ERBB, ERBB1, ERRP, HER1, NISBD2, NNCIS}
- **Diseases:** glioblastoma (MESH:D005909), mesenchymal tumors (MESH:C535700), triple (MESH:C536008), Cancer (MESH:D009369), Primary (MESH:D010538), lung tumor (MESH:D008175), CTC (MESH:D009360), agitation (MESH:D011595), Lung metastasis (MESH:D009362), Breast cancer (MESH:D001943), TNBC (MESH:D064726)
- **Chemicals:** DAPI (MESH:C007293), methanol (MESH:D000432), PI (MESH:D010716), HC (MESH:D006854), Sodium Deoxycholate (MESH:D003840), Propylene Oxide (MESH:C009068), LA (MESH:C037067), SDS (MESH:D012967), Glutaraldehyde (MESH:D005976), 3,3',5-triiodo-L-thyronine (MESH:D014284), Alexa Fluor 647 (MESH:C569686), Biotin (MESH:D001710), L-glutamine (MESH:D005973), phalloidin (MESH:D010590), Luciferin (MESH:D000090562), ACK (-), N-acetylcysteine (MESH:D000111), PVDF (MESH:C024865), H&amp;E (MESH:D006371), monosaccharides (MESH:D009005), Uranyl Acetate (MESH:C005460), ROS (MESH:D017382), copper (MESH:D003300), penicillin (MESH:D010406), NP-40 (MESH:C010615), Osmium Tetroxide (MESH:D009993), Paraformaldehyde (MESH:C003043), DMSO (MESH:D004121), EDTA (MESH:D004492), Ethanol (MESH:D000431), streptomycin (MESH:D013307), Propidium Iodide (MESH:D011419), oil (MESH:D009821), hydrogen (MESH:D006859), polysaccharide (MESH:D011134), HEPES (MESH:D006531), Col (MESH:D003078), water (MESH:D014867), CO2 (MESH:D002245), HA (MESH:D006820), PBS (MESH:D007854), crystal violet (MESH:D005840), silver (MESH:D012834)
- **Species:** Danio rerio (leopard danio, species) [taxon 7955], Mus musculus (house mouse, species) [taxon 10090], Hepatovirus A (no rank) [taxon 12092], Rattus norvegicus (brown rat, species) [taxon 10116], Drosophila melanogaster (fruit fly, species) [taxon 7227], Bos taurus (bovine, species) [taxon 9913], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** PC-3 — Homo sapiens (Human), Prostate carcinoma, Cancer cell line (CVCL_0035), MDA-MB-231 — Homo sapiens (Human), Breast adenocarcinoma, Cancer cell line (CVCL_0062), DAOY — Homo sapiens (Human), Medulloblastoma, SHH-activated, TP53-mutant, Cancer cell line (CVCL_1167), MCF7 — Homo sapiens (Human), Invasive breast carcinoma of no special type, Cancer cell line (CVCL_0031), H1136 — Homo sapiens (Human), Huntington's disease, Finite cell line (CVCL_JB92), pLKO.1 — Mus musculus (Mouse), Hybridoma (CVCL_C7RB), shHAS2 #1 — Rattus norvegicus (Rat), Adenocarcinoma of the rat prostate, Cancer cell line (CVCL_3569), LM2 — Homo sapiens (Human), Breast adenocarcinoma, Cancer cell line (CVCL_5998), MCF10A — Homo sapiens (Human), Spontaneously immortalized cell line (CVCL_0598), WHIM12 — Mus musculus (Mouse), Hybridoma (CVCL_J992), PANC-1 — Homo sapiens (Human), Pancreatic ductal adenocarcinoma, Cancer cell line (CVCL_0480), SKBR3 — Homo sapiens (Human), Breast adenocarcinoma, Cancer cell line (CVCL_0033), PDX — Mus musculus (Mouse), Hybridoma (CVCL_KI95), BT549 — Homo sapiens (Human), Invasive breast carcinoma of no special type, Cancer cell line (CVCL_1092), SUM159 — Homo sapiens (Human), Breast pleomorphic carcinoma, Cancer cell line (CVCL_5423), WHIM12 3D — Mus musculus (Mouse), Hybridoma (CVCL_A7FR), BT474 — Homo sapiens (Human), Invasive breast carcinoma of no special type, Cancer cell line (CVCL_0179), 293FT — Homo sapiens (Human), Transformed cell line (CVCL_6911), pLX304 — Rattus norvegicus (Rat), Transformed cell line (CVCL_9V40)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12881594/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12881594/full.md

## References

13 references — full list in the complete paper: https://tomesphere.com/paper/PMC12881594/full.md

---
Source: https://tomesphere.com/paper/PMC12881594